The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a ...
Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...
The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a ...
Ironfist Therapeutics ("Ironfist"), a preclinical-stage company developing a nanomedicine radiopharmaceutical (Tamrada) that selectively targets tumor associated macrophages without a targeting ligand ...
New research from Indiana University School of Medicine scientists has revealed that a well-known cancer-fighting gene also ...
Tumor-associated macrophages (TAMs) are a dominant immune component within the glioma microenvironment and are increasingly recognized as key contributors to therapeutic resistance, the major ...
ABSTRACT: Objective: To investigate the expression characteristics, clinical significance, and immune regulatory mechanisms of colony stimulating factor receptor α (CSF2RA) in gastric cancer (GC) ...
State Key Lab of Medicinal Chemical Biology, School of Medicine, College of Pharmacy, Nankai University, Tianjin 300071, China State Key Laboratory of Experimental Hematology, National Clinical ...
Abstract: Traditional models for brain tumor diagnosis often struggle with limited prediction accuracy, largely due to their inability to fully capture the heterogeneous nature and complexity of tumor ...
The tumor microenvironment significantly influences the aggressive invasive characteristics of human solid tumors, with the infiltration of immune cells being a defining feature of tumor advancement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback